Remel Recalls Yeastone Broth Over False Test Results
Remel, Inc. is recalling Yeastone Broth after testing showed it may report false susceptibility to certain antifungal agents.
Remel, Inc. is recalling Yeastone Broth, 11ML, 10/BOX. The product is used in antibiotic susceptibility testing of mycological clinical specimens.
The recall was initiated because the affected product did not meet specifications. The broth may report false susceptibility to antifungal agents, specifically within the Azole family.
The product was distributed in the United States in California and Massachusetts, as well as internationally to India, Saudi Arabia, and the United Kingdom. The action is classified as a Class II recall by the U.S. Food and Drug Administration.
What to do
- Stop using the recalled Yeastone Broth immediately.
- Quarantine any remaining affected product to prevent its use in testing.
- Contact Remel, Inc. or the FDA for further instructions regarding the recall.
At a glance
| Agency | U.S. Food and Drug Administration (FDA) |
|---|---|
| Recall number | Z-0355-2027 |
| Date | 2026-11-11 |
| Company | Remel, Inc, Lenexa, KS |
| Severity | Class II |
| Quantity | 33 US, 54 OUS |
| Where sold | Worldwide – US Nationwide distribution in the states of MA and CA. The countries of India, Saudi Arabia, UK. |
| Lot codes / identifiers | YY3462 lot 440400 UDI-DI 848838018817 |
Source: official FDA notice. This summary was written by 365 News from the official notice. Details can change; check the notice before acting.